Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials

Buck, D; Andlauer, TF; Igl, W; Wicklein, E-M; Mühlau, M; Weber, F; Köchert, K; ... BEYOND and BENEFIT Study Groups, ; + view all Buck, D; Andlauer, TF; Igl, W; Wicklein, E-M; Mühlau, M; Weber, F; Köchert, K; Pohl, C; Arnason, B; Comi, G; Cook, S; Filippi, M; Hartung, H-P; Jeffery, D; Kappos, L; Barkhof, F; Edan, G; Freedman, MS; Montalbán, X; Müller-Myhsok, B; Hemmer, B; BEYOND and BENEFIT Study Groups, ; - view fewer (2018) Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials. Multiple Sclerosis Journal 10.1177/1352458518763089 . (In press). Green open access

https://ift.tt/2HmC2xB